Author:
Ke Shaoyong,Huang Wenbo,Zhang Zhigang,Wang Yueying,Zhang Yani,Wu Zhaoyuan,Fang Wei,Wan Zhongyi,Gong Yan,Yang Jingzhong,Wang Kaimei,Shi Liqiao
Abstract
Diarylamines are a class of important skeleton widely existing in drugs or natural products. To discover novel diarylamine analogues as potential drugs, two series of diamide and carboxamide derivatives containing diarylamine scaffold were designed, synthesized and evaluated for their potential cytotoxic activities. The bioassay results indicated that some of the obtained compounds (C5, C6, C7, C11) exhibited good cytotoxic effect on cancer cell lines (SGC-7901, A875, HepG2), especially, compound C11 present significantly selective proliferation inhibition activity on cancer and normal cell lines (MARC145). In addition, the possible apoptosis induction for highly potential molecules was investigated, which present compound C11 could be used as novel lead compound for discovery of promising anticancer agents.
Reference35 articles.
1. AACR Cancer Progress Report2019
2. Diarylamides in Anticancer Drug Discovery: A Review of Pre-clinical and Clinical Investigations;Abduelkarem;Eur. J. Med. Chem.,2020
3. Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay;Alley;Cancer Res.,1988
4. Tryptamine Derivatives Disarm Colistin Resistance in Polymyxin-Resistant Gram-Negative Bacteria;Barker;Bioorg. Med. Chem.,2019